15-deoxy-delta-12,14-PGJ2

15-deoxy-delta-12,14-pgj2 is a lipid of Fatty Acyls (FA) class. 15-deoxy-delta-12,14-pgj2 is associated with abnormalities such as Dehydration and Myocardial Ischemia. The involved functions are known as Binding (Molecular Function), Inflammation, Alveolar ventilation function, Stimulus and Process. 15-deoxy-delta-12,14-pgj2 often locates in Cytosol, Myocardial tissue and Heart tissue. The associated genes with 15-deoxy-delta-12,14-PGJ2 are Homologous Gene and G-substrate. The related lipids are 15-deoxyprostaglandin J2 and Lipopolysaccharides.

Cross Reference

Introduction

To understand associated biological information of 15-deoxy-delta-12,14-PGJ2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 15-deoxy-delta-12,14-PGJ2?

15-deoxy-delta-12,14-PGJ2 is suspected in Dehydration, Myocardial Ischemia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 15-deoxy-delta-12,14-PGJ2

MeSH term MeSH ID Detail
Actinobacillus Infections D000189 4 associated lipids
Arteriosclerosis D001161 86 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Body Weight D001835 333 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Brain Ischemia D002545 89 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Fibrosis D005355 23 associated lipids
Goiter D006042 4 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hyperalgesia D006930 42 associated lipids
Inflammation D007249 119 associated lipids
Insulin Resistance D007333 99 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Lung Neoplasms D008175 171 associated lipids
Myocardial Infarction D009203 21 associated lipids
Pain D010146 64 associated lipids
Per page 10 20 50 | Total 30

PubChem Associated disorders and diseases

What pathways are associated with 15-deoxy-delta-12,14-PGJ2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 15-deoxy-delta-12,14-PGJ2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 15-deoxy-delta-12,14-PGJ2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 15-deoxy-delta-12,14-PGJ2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 15-deoxy-delta-12,14-PGJ2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 15-deoxy-delta-12,14-PGJ2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 15-deoxy-delta-12,14-PGJ2

Download all related citations
Per page 10 20 50 100 | Total 940
Authors Title Published Journal PubMed Link
Kim HY and Kim HS Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages. 2007 Immunol. Cell Biol. pmid:17130903
Tanaka Y et al. Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. 2007 Mol. Pharmacol. pmid:17151289
Ueki S et al. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions. 2007 Int. Arch. Allergy Immunol. pmid:17541271
Engdahl R et al. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-alpha by decreasing levels of acetylated histone H3 and H4 at its promoter. 2007 Biochem. Biophys. Res. Commun. pmid:17532302
Vunta H et al. The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. 2007 J. Biol. Chem. pmid:17439952
Fulzele SV et al. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors. 2007 Anticancer Drugs pmid:17159504
Arnold R et al. Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells. 2007 Immunology pmid:17425601
Xiang Z et al. 15d-PGJ2 induces apoptosis of mouse oligodendrocyte precursor cells. 2007 J Neuroinflammation pmid:17634127
Ye Y et al. Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2. 2007 Prostaglandins Other Lipid Mediat. pmid:17643887
Paukkeri EL et al. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages. 2007 Br. J. Pharmacol. pmid:17891158
Lin TH et al. PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. 2007 Bone pmid:17669705
Fionda C et al. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes. 2007 Mol. Pharmacol. pmid:17673570
Ou YC et al. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. 2007 Eur. J. Pharmacol. pmid:17341418
Schlezinger JJ et al. An L-tyrosine derivative and PPARgamma agonist, GW7845, activates a multifaceted caspase cascade in bone marrow B cells. 2007 Toxicol. Sci. pmid:17400580
Kim WJ et al. Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A. 2007 EMBO J. pmid:18034160
Haworth O and Buckley CD Resolving the problem of persistence in the switch from acute to chronic inflammation. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:18093938
Wu P et al. Inflammation pro-resolving potential of 3,4-dihydroxyacetophenone through 15-deoxy-delta12,14-prostaglandin J2 in murine macrophages. 2007 Int. Immunopharmacol. pmid:17761349
Saito Y et al. Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione. 2007 J. Neurochem. pmid:17697048
Kondoh K et al. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells. 2007 Exp. Cell Res. pmid:17706193
Richard CL et al. 15-Deoxy-delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPARgamma- and NFkappaB-mediated pathways. 2007 Exp. Cell Res. pmid:17707368
Kamagata C et al. 15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression. 2007 Breast Cancer Res. Treat. pmid:17028981
Moon Y et al. Hypo-responsiveness of interleukin-8 production in human embryonic epithelial intestine 407 cells independent of NF-kappaB pathway: new lessons from endotoxin and ribotoxic deoxynivalenol. 2008 Toxicol. Appl. Pharmacol. pmid:18485432
Copple IM et al. The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system. 2008 Hepatology pmid:18785192
Poncin S et al. Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. 2008 Endocrinology pmid:17884933
Su RY et al. 15-deoxy-Delta12,14-prostaglandin J2 up-regulates death receptor 5 gene expression in HCT116 cells: involvement of reactive oxygen species and C/EBP homologous transcription factor gene transcription. 2008 Mol. Cancer Ther. pmid:18852146
Nagata D et al. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer. 2008 Cancer Detect. Prev. pmid:18789607
Cruz-Orengo L et al. Cutaneous nociception evoked by 15-delta PGJ2 via activation of ion channel TRPA1. 2008 Mol Pain pmid:18671867
Oku H and Umino T Molecular characterization of peroxisome proliferator-activated receptors (PPARs) and their gene expression in the differentiating adipocytes of red sea bream Pagrus major. 2008 Comp. Biochem. Physiol. B, Biochem. Mol. Biol. pmid:18691667
Genovese T et al. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury. 2008 Shock pmid:18628687
Capobianco E et al. Effects of natural ligands of PPARgamma on lipid metabolism in placental tissues from healthy and diabetic rats. 2008 Mol. Hum. Reprod. pmid:18621767
Tonge D et al. Enhancement of axonal regeneration by in vitro conditioning and its inhibition by cyclopentenone prostaglandins. 2008 J. Cell. Sci. pmid:18650498
Kim EH and Surh YJ The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis. 2008 Biochem. Pharmacol. pmid:18771658
Kim JW et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2) rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2. 2008 Biochem. Pharmacol. pmid:18775681
Ho TC et al. 15-deoxy-Delta(12,14)-prostaglandin J2 induces vascular endothelial cell apoptosis through the sequential activation of MAPKS and p53. 2008 J. Biol. Chem. pmid:18718914
Lian TW et al. Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages. 2008 Biochim. Biophys. Acta pmid:18662803
Jozkowicz A et al. 15d-PGJ2 upregulates synthesis of IL-8 in endothelial cells through induction of oxidative stress. 2008 Antioxid. Redox Signal. pmid:18665800
Napimoga MH et al. Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway. 2008 J. Immunol. pmid:18097063
Dubourdeau M et al. Opposite roles of STAT and PPARgamma in the induction of p21WAF1 expression by IL-13 in human peripheral blood monocytes. 2008 Eur. Cytokine Netw. pmid:19103521
García-Bueno B et al. Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats. 2008 Endocrinology pmid:18079203
Muñoz U et al. On the mechanism of inhibition of p27 degradation by 15-deoxy-Delta12,14-prostaglandin J2 in lymphoblasts of Alzheimer's disease patients. 2008 Cell. Mol. Life Sci. pmid:18818877
Ferreira-Silva V et al. Effects of 15-deoxy-Delta12, 14 prostaglandin J2 and ciglitazone on human cancer cell cycle progression and death: the role of PPARgamma. 2008 Eur. J. Pharmacol. pmid:18054911
Kuboki S et al. Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. 2008 Hepatology pmid:18085707
Lutzow YS et al. 15-Deoxy-Delta12,14-prostaglandin J2 induces chemokine expression, oxidative stress and microfilament reorganization in bovine mammary epithelial cells. 2008 J. Dairy Res. pmid:18226310
Kerr BJ et al. The protective effects of 15-deoxy-delta-(12,14)-prostaglandin J2 in spinal cord injury. 2008 Glia pmid:18205174
Choi IK et al. PPAR-gamma ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivo. 2008 Invest New Drugs pmid:18161004
Hounoki H et al. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression. 2008 Bone pmid:18242157
Kim EH et al. 15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS. 2008 Carcinogenesis pmid:18192694
Crabb SJ et al. BAG-1 inhibits PPARgamma-induced cell death, but not PPARgamma-induced transcription, cell cycle arrest or differentiation in breast cancer cells. 2008 Oncol. Rep. pmid:18288403
Hong HY et al. Up-regulation of heme oxygenase-1 expression through the Rac1/NADPH oxidase/ROS/p38 signaling cascade mediates the anti-inflammatory effect of 15-deoxy-delta 12,14-prostaglandin J2 in murine macrophages. 2008 FEBS Lett. pmid:18291107
Kimura H et al. A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions. 2008 Nephrol. Dial. Transplant. pmid:18367541